News
5h
MyChesCo on MSNFDA Approves Gardenia Blue as Natural Dye in Major Move to Eliminate Synthetic Food ColorsThe U.S. Food and Drug Administration (FDA) has approved the use of gardenia (genipin) blue as a color additive in a range of food products, marking the fourth ...
The FDA is targeting ultraprocessed foods for reform to improve healthfulness of children's food. Whether the approach is comprehensive remains to be seen.
Food and Drug Administration Commissioner Dr. Marty Makary joins 'Fox & Friends Weekend' to discuss the MAHA push as major ...
18h
New Vision on MSNUS may revise hormone replacement therapy warnings"Not only is there no clinical trial showing an increase in breast cancer mortality, but there are also other tremendous long term health benefits," Makary added.
When three patients die after taking a cutting-edge drug, most companies hit the brakes. Not Sarepta Therapeutics. The ...
23h
Health and Me on MSNArtificial Dyes Set To Disappear From 90% Of U.S. Ice Cream By 2028By 2028, nearly 90% of ice cream and frozen desserts sold in the United States will be free from artificial food dyes, according to a new announcement by federal health officials and the International ...
Explore more
1d
Health and Me on MSN"Obsolete And Unnecessary": FDA Set To Revoke 52 Nutrition And Labeling RulesThe FDA plans to revoke 52 outdated nutrition and labeling regulations to streamline food industry standards, citing them as ...
Pharmaceutical manufacturing in the U.S. has declined sharply over recent decades, with most active ingredient production shifting overseas due to lower labor costs. In 2023, the U.S.
(NEXSTAR) — Dozens of companies that make ice cream and frozen dairy desserts announced on Monday that they would remove artificial food dyes from their products by 2028, marking yet another voluntary ...
Sarepta Therapeutics announced late Friday evening that it will not comply with the Food and Drug Administration's ...
In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug ...
Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results